The World's Leading Manufacturer of Hyaluronic Acid
-
December 2021
Waterble® Microbial fermentation patent "A Streptococcus epizoosis and its production process for producing hyaluronic acid" won the "Government Patent Award"
-
November 2021
Joint innovation laboratory was established with Jiangnan University
-
August 2021
Rated as Specialized and New Enterprise
-
March 2021
CEP Certification issued by the EDQM (European Directorate for the Quality of Medicines & HealthCare)
-
December 2020
Rated as a High-tech Enterprise & Gazelle Company
-
November 2020
The patent for preparation of ultra-low molecular hyaluronic acid by ProEnzy® enzyme digestion method was approved
-
June 2020
Obtain the National Medical Products Administration's API registration
-
March 2020
Signed joint research and development cooperation with Qilu University
-
October 2019
Obtain the registration of pharmaceutical excipients from the National Medical Products Administration
-
May 2019
Established a key engineering research center for active polysaccharides
-
March 2019
Established R&D Center with Shandong Academy of Pharmaceutical Sciences
-
April 2018
Rated as a National Science and Technology Enterprise
-
December 2017
Recognized as a High-tech Enterprise
-
September 2017
Phase II Expansion Project put into operation
-
June 2015
Shareholding reform, successfully listed the NEEQ
-
June 2014
The patent for the production of hyaluronic acid by Waterble® microbial fermentation was approved
-
January 2014
Get certification of ECOCERT / COSMOS
-
March 2012
The first phase of construction was completed and sodium hyaluronate was officially put into production
-
2010年7月
设立安华生物滨州工厂